DRUG DISCOVERY FEATURED ARTICLES & APPLICATIONS

  • Tools for the Design of Vaccines to Help Reduce Clinical Failure
    Tools for the Design of Vaccines to Help Reduce Clinical Failure

    If you are involved in the pharma industry, then you are interested in saving lives. In the area of preventative medicine, therapeutic vaccines have proven to have a tremendous impact on the ability to save millions of lives. Similar to pharmaceuticals, vaccine development can take over 10 years and less than 10 percent of candidates reach commercialization. Reducing the cost of failure and increasing the chances of clinical success for vaccines is beneficial to both the pharma industry and those being treated for or protected from disease.

  • Patheon Surfs Outsourcing Waves And Scoops Up Gallus Along The Way

    Jim Mullen, CEO of Patheon parent company DPx Holdings B.V., is at it again.

    On the heels of my three-part series with Mullen on the details behind the springtime merger of his company and the pharmaceutical products division of Royal DSM, he has made his next move.

    This time it is a strategic entrée into the U.S.-based market for biologics services via an acquisition of privately held Gallus BioPharmaceuticals. With Gallus, Patheon adds new capabilities at well-established sites with name-brand clientele, in St. Louis, Mo. and Princeton, N.J., to its global locations in Groningen, the Netherlands and Brisbane, Australia.

  • Systematic Method Development Of UPC2 Conditions Using Opioid Drugs

    This application note uses a panel of natural and synthetic opioid drugs to demonstrate the use of a systematic screening strategy for UPC2 method development. By Jonathan P. Danaceau, Kenneth J. Fountain, and Erin E. Chambers, Waters Corporation

  • A Single-Injection UPC2 Method For Fast And Simultaneous Separation Of Nine Fat-Soluble Vitamins

    Fat-soluble vitamins(FSVs) include vitamins A, D, E, K and carotenoids such as β-carotene. The FSVs are involved in complex metabolic reactions related to important biological functions such as vision (vitamin A), calcium absorption (vitamin D), antioxidant protection of cell membrane (vitamin E), and blood coagulation (vitamin K). By Rui Chen, Jinchuan Yang, and John McCauley, Waters Corporation

  • Lipid Class Separation Using UPC2/MS

    A flexible, universal method was developed for the analysis of inter-class separations of neutral and amphipathetic lipids. By Michael D. Jones, Giorgis Isaac, Giuseppe Astarita, Andrew Aubin, John Shockcor, Vladimir Shulaev, Cristina Legido-Quigley, and Norman Smith

More From Featured Articles

LATEST NEWS

  • Cerenis Receives EMA Orphan Drug Designations For CER-001 For The Treatment Of ApoA-I And ABCA-1 Deficiencies

    Cerenis Therapeutics, the biopharmaceutical company developing CER-001, an engineered human apoA-I-containing pre-beta HDL mimetic, for the treatment of cardiovascular disease, recently announced that it has received two separate Orphan Drug Designations from the European Medicines Agency (EMA) for the use of CER-001 in the treatment of patients with rare genetic defects in HDL synthesis/maturation pathways, specifically apoA-I deficiency and ABCA1 deficiency

More....

FEATURED PRODUCTS AND SERVICES

Contract Manufacturing: Cytotoxics

Contract Manufacturing: Cytotoxics

As a global parenteral drug leader with more than 75 years of experience, Baxter knows how to get your product to market with proven efficiency and reliability. Integrated, state-of-the-art resources dedicated exclusively to cytotoxic and high-potency product manufacturing ensure your molecule moves smoothly from development and clinical trials right through full-scale commercial manufacturing.
Drug Lifecycle Management Services

Drug Lifecycle Management Services

With fully integrated services and the experience of more than 50 successful lifecycle management projects, Patheon can quickly and cost-effectively take your compound from preformulation to large-scale manufacturing.

Biologics Manufacturing

Biologics Manufacturing

Abbott offers you state-of-the-art Biologics Manufacturing Capabilities, including Smart solutions to process design, analytical characterization and cGMP manufacturing, supporting the development and commercialization of your biopharmaceutical product. As an innovator, Abbott understands the importance of a Strong and Secure relationship with our partners.
12 x 32 mm µL Vials with Low Dead Volume

12 x 32 mm µL Vials with Low Dead Volume

µLVials give you the most effective means of sampling small volumes without the use of expensive micro-vials and harder to fill inserts
QitTof™

QitTof™

Quadrupole ion traps (QITs) are an effective means to accumulate ions

Cell Culture Services

We can prepare small or large quantities of adherent or suspension cell cultures, according to your specifications, in our large cell culture facility
More Featured Products
Newsletter Signup
Newsletter Signup
Get the latest industry news, insights, and analysis delivered to your inbox.
Join your peers
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.

INDUSTRY EVENTS

Vendor Qualification and Compliance: What Sponsors & CMOs Must Know

September 17, 2014
1pm-2:30pm EST, Online Training

DIA Biosimilars 2014, September 18-19, Washington, DC

September 18 - 19, 2014
Washington, DC

EDM and ERS 2014

September 22 - 24, 2014
Washington, DC
More Events....

 UPCOMING TRAINING COURSES

Vendor Qualification and Compliance: What Sponsors & CMOs Must Know

September 17, 2014
1pm-2:30pm EST, Online Training

CRA Oversight - A Risk-based Approach

September 23, 2014
1pm-2:30pm EDT, Online Training

It's Ten O'Clock. Do You Know Where Your Trial Master File Is?

September 24, 2014
1pm-2:30pm EDT, Online Training
More Upcoming Courses

PREMIER SERVICE PROVIDER